Summary
3M Company (MMM) filed an 8-K on April 4, 2003, to provide supplemental unaudited financial information reflecting its newly realigned business segments, effective January 1, 2003. This restructuring resulted in seven reportable segments, up from six. The filing includes historical financial data for the years 2000, 2001, and 2002, presented on an annual and quarterly basis according to the new segment structure. This allows investors to analyze performance under the reorganized framework prior to the official reporting of comparative results in the Q1 2003 10-Q. The data shows net sales and operating income for each of the seven segments (Health Care, Industrial, Consumer and Office, Display and Graphics, Electro and Communications, Safety, Security and Protection Services, and Transportation) as well as a Corporate and Unallocated category. Notably, the company also disclosed accounting adjustments related to "Vendor Income Statement Characterization of Consideration Paid to a Reseller" (EITF 00-25), which reclassified approximately $25 million of advertising expenses as net sales for 2001 and 2000, without impacting operating income. Restructuring charges and other one-time items were also detailed for the periods presented.
Key Highlights
- 13M is providing historical financial data (2000-2002) under a new seven-segment business structure, effective January 1, 2003.
- 2The new segment structure provides a closer focus on markets and customers, aiming for faster growth.
- 3Supplemental data includes Net Sales and Operating Income by segment, both quarterly and annually.
- 4The Health Care segment consistently showed strong Net Sales and Operating Income growth across the reported periods.
- 5The 'Electro and Communications' segment experienced a decline in both Net Sales and Operating Income from 2000 to 2002.
- 6The company adopted EITF 00-25, reclassifying approximately $25 million of advertising expenses to net sales for 2001-2000, with no operating income impact.
- 7Significant restructuring charges and other one-time items (e.g., perfluorooctanyl phase-out, asset dispositions, litigation accruals) impacted operating income in the 2000-2002 periods, particularly within the 'Corporate and Unallocated' segment.